logo
Select company
Select metric
$ 84.05MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
55
Sector
84
Industry
84
History
100
$ 6.66Close
$ 6.14 - $ 13.71 52-Week Range
Ticker Information

Ticker

BVS

Company Name

BIOVENTUS INC

Sector

Healthcare

Industry

Medical Devices

Exchange

NASDAQ

BIOVENTUS INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

BVS - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 48.59M$ 35.46M$ 84.05M
3/31/2025$ 49.63M$ -1.94M$ 47.69M
12/31/2024$ 49.55M$ -43K$ 49.51M
9/30/2024$ 49.62M$ -6M$ 43.62M
6/30/2024$ 51.17M$ -7.88M$ 43.28M
3/31/2024$ 52.68M$ 20.81M$ 73.49M
12/31/2023$ 57.37M$ -115.47M$ -58.1M
9/30/2023$ 68.06M$ -140.8M$ -72.74M
6/30/2023$ 73.01M$ -284.34M$ -211.33M
3/31/2023$ 70.8M$ -295.06M$ -224.26M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • BIOVENTUS INC's latest trailing twelve months (TTM) EBITDA stands at $ 60.32M.
  • Over the past 5 years, BIOVENTUS INC's average EBITDA has been $ -10.18M.
  • The median EBITDA for BIOVENTUS INC during this period was $ 43.45M
  • BIOVENTUS INC reached its highest EBITDA over the past 5 years at $ 84.05M.
  • The lowest EBITDA recorded by BIOVENTUS INC in the same timeframe $ -224.26M

BIOVENTUS INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
ZIMV : ZIMVIE INC $ 42.62MAVNS : AVANOS MEDICAL INC $ -426.6MOFIX : ORTHOFIX MEDICAL INC $ -11.65MAXGN : AXOGEN INC $ 10.84MSIBN : SI-BONE INC $ -15.81MCTKB : CYTEK BIOSCIENCES INC $ 9.23MKIDS : ORTHOPEDIATRICS CORP $ -19.62MORGO : ORGANOGENESIS HOLDINGS INC $ 3.01MARAY : ACCURAY INC $ 20.24MVREX : VAREX IMAGING CORP $ -9.9M

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA
EBITDA for BIOVENTUS INC is calculated as follows: EBIT [ $ 30.01M ] + DepAmor [ $ 30.32M ]
(=) EBITDA [ $ 60.32M ]

BVS - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -224.26M

Minimum

Mar 31, 2023

$ 84.05M

Maximum

Jun 30, 2025

$ -10.18M

Average

$ 43.45M

Median

EBITDA Benchmark Analysis

The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.79M with a standard deviation of $ 166.94M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.25K
min$ -493.3M
max$ 590.6M
average$ 58.79M
median$ 8.83M
std$ 166.94M